Showing results (51-60 of 356) with videos related to
Sort By:
Pageof 36
Frontiers in Pharmacology|August 21, 2019
Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A ReviewPilar Irún, Angel Lanas, Elena PiazueloDiagnostics (Basel, Switzerland)|June 10, 2023
Diagnosis and Treatment ofEnrique Alfaro, Carlos Sostres, Angel LanasCurrent Pharmaceutical Design|September 16, 2015
A Balanced View of Efficacy and Safety of Aspirin in Cardiovascular DiseasesRubén Casado-Arroyo, Angel Lanas, Pedro BrugadaExpert Review of Clinical Pharmacology|August 25, 2018
NSAID induced gastrointestinal damage and designing GI-sparing NSAIDsGuillermo García-Rayado, Mercedes Navarro, Angel LanasWorld Journal of Gastrointestinal Pharmacology and Therapeutics|March 8, 2014
Aspirin, cyclooxygenase inhibition and colorectal cancerCarlos Sostres, Carla Jerusalen Gargallo, Angel LanasCurrent Pharmaceutical Design|October 8, 2003
Clinical implications of COX-1 and/or COX-2 inhibition for the distal gastrointestinal tractAngel Lanas, Julián Panés, Josep M PiquéCurrent Medical Research and Opinion|June 2, 2017
Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practiceCarlos Sostres, Patrica Carrera-Lasfuentes, Angel LanasArthritis Research & Therapy|November 26, 2013
Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damageCarlos Sostres, Carla J Gargallo, Angel LanasExpert Review of Clinical Pharmacology|May 3, 2017
Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersGuillermo García-Rayado, Carlos Sostres, Angel LanasAnnals of the Rheumatic Diseases|May 26, 2010
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA studyAngel Lanas, Jesús Tornero, José Luis ZamoranoPageof 36